HBE1 and chronic hepatitis: In some patients, the immune-control phase of chronic hepatitis is followed by an HBeAg-negative (sometimes called “immune escape-mutant”) phase, which is characterized by a lack of serum HBeAg with detectable anti-HBe antibodies, moderate to high levels of HBV DNA (>2000 IU/mL), and more rapid progression of liver disease.